Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development	$ 7,247	$ 3,084	$ 12,390	$ 8,353
General and administrative	4,893	5,621	9,482	11,226
Total operating expenses	12,140	8,705	21,872	19,579
Loss from operations	(12,140)	(8,705)	(21,872)	(19,579)
Other income (expense), net:
Interest and investment income	846	166	1,533	285
Other income (expense), net	846	166	1,533	285
Net loss	$ (11,294)	$ (8,539)	$ (20,339)	$ (19,294)
Net loss per share attributable to common stockholders, basic and diluted (in Dollars per share)	$ (1)	$ (0.76)	$ (1.8)	$ (1.71)
Weighted-average shares outstanding, basic and diluted (in Shares)	11,307,842	11,255,215	11,305,867	11,252,686
Other comprehensive income (loss):
Net unrealized gain (loss) on marketable debt securities	$ 133	$ (180)	$ 352	$ (911)
Other comprehensive income (loss)	133	(180)	352	(911)
Comprehensive Loss	$ (11,161)	$ (8,719)	$ (19,987)	$ (20,205)